| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects
|
He, Pei
|
|
2015
|
1 |
C |
p. 28-31
4 p.
|
article
|
| 2 |
A two-stage design with two co-primary endpoints
|
Song, James X.
|
|
2015
|
1 |
C |
p. 2-4
3 p.
|
article
|
| 3 |
Blinding properties of methods for supplying drug kits to investigational sites
|
Yu, Ron
|
|
2015
|
1 |
C |
p. 22-27
6 p.
|
article
|
| 4 |
Editorial
|
Jin, Zhezhen
|
|
2015
|
1 |
C |
p. A1-
1 p.
|
article
|
| 5 |
Real-time enrollment dashboard for multisite clinical trials
|
Mattingly, William A.
|
|
2015
|
1 |
C |
p. 17-21
5 p.
|
article
|
| 6 |
Resveratrol does not reduce CVD risk, prolong life – A statistical point of view
|
Xie, Changchun
|
|
2015
|
1 |
C |
p. 1-
1 p.
|
article
|
| 7 |
The relationship between external and internal validity of randomized controlled trials: A sample of hypertension trials from China
|
Zhang, Xin
|
|
2015
|
1 |
C |
p. 32-38
7 p.
|
article
|
| 8 |
Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?
|
Stuntz, Mark
|
|
2015
|
1 |
C |
p. 39-41
3 p.
|
article
|
| 9 |
Trend-constrained corrected score for proportional hazards model with covariate measurement error
|
Zhu, Ming
|
|
2015
|
1 |
C |
p. 5-16
12 p.
|
article
|
Journal description